Front Row Fund
VC Fund
Newtown, United States
Front Row Fund is a seed and early-stage venture capital fund. We invest in companies in a broad range of industries and verticals that are technology-driven, or better yet, undergoing a technological evolution.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Front Row Fund invests in
Stages Front Row Fund invests in
Countries Front Row Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Haines
|
|||
Haig Hengen
|
|||
Michael Korsky
|
|||
Val Shtraks
|
|||
1 more contact available
Investment Focus
Industry
- Software 3 (33%)
- Artificial Intelligence 3 (33%)
- Productivity Tools 2 (22%)
- FinTech 1 (11%)
- Payments 1 (11%)
Stage
- Seed 6 (67%)
- Pre-Seed 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
David Haines
Partner
|
Partner | Total investments: 2 | Find email | |
|
Haig Hengen
Investment Analyst
|
Investment Analyst | Total investments: 0 | Find email | |
|
Michael Korsky
General Partner
|
General Partner | Total investments: 0 | Find email | |
|
Val Shtraks
General Partner
|
General Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Atacama Biomaterials
|
Atacama Biomaterials is an AI driven biotech company that offers compostable and biodegradable plastic alternatives. | $500K / Pre-Seed / Mar 01, 2023 | |
Gatehouse Bio
|
Gatehouse Bio is a biotechnology company focused on advancing precision medicine to accelerate the development of next-gen therapeutics.Their technology is based on a patented, revolutionary approach to uncover small RNA (sRNA) signatures of disease using biology influenced machine learning. sRNA signatures provide a platform for drug discoveryand drug repurposing, and have been validated in cardiology, neurology, oncology, respiratory and rare diseases by industry leaders and the FDA.They have unique business model that promotes collaboration with leading drug developers to identify novel drug targets and discover companion diagnostics. | $2.5M / Seed / Dec 08, 2021 | |
CareAlign
|
CareAlign provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more. | $2.3M / Seed / Nov 30, 2021 | |
PreShow
|
PreShow provides a concept that makes moviegoing completely free by connecting brands with moviegoers on a one-to-one basis. Its app features a new proprietary platform where consumers can earn the ability to see movies in theaters for free. The company was founded in 2019 and is headquartered in New York. | $3M / Seed / Apr 29, 2021 | |
Qoins
|
Qoins is a financial wellness app that helps consumers achieve their financial goals by combining financial education and automation. Qoins develops an automated micro-payment platform created to pay off debt early with the spare change from bank transactions. The platform uses round-up technology on daily credit card purchases and calculates sparechange from the previous month and makes an additional payment to users' student loans or credit cards, enabling them to save money and get more purchasing power in the future. | $1.5M / Seed / Jan 12, 2021 | |
|
Gatehouse Bio
|
Gatehouse Bio is a biotechnology company focused on advancing precision medicine to accelerate the development of next-gen therapeutics.Their technology is based on a patented, revolutionary approach to uncover small RNA (sRNA) signatures of disease using biology influenced machine learning. sRNA signatures provide a platform for drug discoveryand drug repurposing, and have been validated in cardiology, neurology, oncology, respiratory and rare diseases by industry leaders and the FDA.They have unique business model that promotes collaboration with leading drug developers to identify novel drug targets and discover companion diagnostics. | $2.5M / Seed / Jan 07, 2021 | |
|
CareAlign
|
CareAlign provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more. | $1M / Seed / Jul 29, 2020 | |
ChoiceWORX
|
ChoiceWORX is an intelligent automation software company that is revolutionizing IT Operations. Its AI-driven solutions leverage the power and scalability of AI to automate End-user IT support and RPA operations and management. ChoiceWORX's solutions allow companies to significantly reduce costs, drastically improve worker productivity, andreduce dependence on human labor. | $3.6M / Seed / Apr 17, 2020 | |
Notiv
|
Being fully present in a meeting and capturing highly detailed notes at the same time is close to impossible. Notiv is the intelligent meeting assistant that captures and automatically transcribes all your essential voice conversations into clever business outcomes so that you can focus on the present.Notiv can be used for all your importantvoice meetings, so that you or your teams can focus on higher-order tasks, augmenting all your contemporaneous note-taking workflows.Whether it is to refresh your memory from last week's client briefing, have Notiv join a meeting or workshop on your behalf, or improve your firm's governance and compliance capabilities. With multiple use cases and capabilities, Notiv has you covered! | $1.5M / Seed / Mar 20, 2020 |
Co-Investors
Tech Council Ventures
3 deals together
Boston Millennia Partners
2 deals together
Black Nova Venture Capital
1 deal together
Canaan Partners
1 deal together
CFV Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Front Row Fund invest in?
Front Row Fund invests primarily in Software, Artificial Intelligence and Productivity Tools startups, most often at Seed and Pre-Seed stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Front Row Fund?
Public channels for Front Row Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Front Row Fund?
The team at Front Row Fund includes David Haines (Partner), Haig Hengen (Investment Analyst) and Michael Korsky (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
